Skip to main content
    O

    OKYO Pharma Limited (OKYO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.18
    -0.18 (-12.96%)

    Market Cap: $70.85M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    17%(1/6)
    Avg Surprise
    -36.33%

    Upcoming Estimates

    Results pendingPeriod ending Sep 30, 2026
    EPS Consensus-$0.04
    Range-$0.04 - -$0.04
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago-$0.040.0%
    30d ago-$0.040.0%
    7d ago-$0.040.0%
    Current-$0.04
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts
    Last 12 of 13 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Sep 26EST
    Date TBD
    --$0.04-$0.04 - -$0.04--1
    No revisions (30d)
    -
    Jun 26
    Reported Jul 20
    N/A-$0.03-$0.03 - -$0.03--1
    No revisions (30d)
    -
    Mar 26
    Reported Jun 3
    N/A-$0.03-$0.03 - -$0.03--1
    0
    1
    30d
    -
    Dec 25
    Reported Jan 30
    Not reported-$0.04N/A--1
    0
    1
    30d
    -
    Sep 25
    Reported Sep 30
    N/A-$0.02-$0.02 - -$0.02--1
    1
    0
    30d
    -
    Jun 25
    Reported Aug 5
    -$0.06-$0.05N/A-20.00%Miss1
    1
    0
    30d
    +33.3%
    Mar 25
    Reported Mar 31
    N/A-$0.05N/A--0
    No revisions (30d)
    -
    Dec 24
    Reported Jan 29
    -$0.08-$0.09N/A+11.11%Beat0
    No revisions (30d)
    +20.0%
    Sep 24
    Reported Sep 30
    N/A-$0.09N/A-----
    Jun 24
    Reported Aug 13
    -$0.09-$0.09N/A0.00%In line--+73.5%
    Mar 24
    Reported May 13
    N/A-$0.09N/A-----
    Dec 23
    Reported Jan 9
    -$0.10-$0.10N/A0.00%In line---
    Sep 23
    Reported Dec 28
    -$0.11-$0.11N/A0.00%In line---

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-4.84xFCF Yield-20.68%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-263.80%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.43xQuick Ratio2.43x
    Trading Statistics
    Beta-0.14Avg Volume253.22K
    52-Week High$3.2052-Week Low$1.20

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 16.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 33.6, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.37
    SMA 20$1.42
    SMA 50$1.40
    SMA 200$1.57
    EMA 10$1.36
    EMA 20$1.39
    EMA 50$1.42
    EMA 200$1.59

    MACD

    Line: -0.03Signal: -0.01Hist: -0.02

    ADX

    ADX: 15.3+DI: 11.5-DI: 19.2

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down100.0
    PSAR$1.41

    Bollinger Bands

    Upper Band$1.58
    Lower Band$1.25
    %B Position2320%(Upper)
    Band Width-0.24

    RSI (14-Day)

    Neutral
    33.6

    Momentum Oscillators

    Stoch %K32.7
    Stoch %D42.9
    Williams %R-93.5
    ROC (10d)-19.5%
    Momentum-0.28
    CCI (20d)-237.5
    MFI (14d)7.5

    Volatility Measures

    ATR (14d)$0.12(10.4%)
    StdDev (20d)0.08
    Hist Vol88.5%(High)

    Volume Flow

    VWAP$1.22
    OBV-42.2K
    AD Line-3.9M
    CMF (20d)-0.453

    Volume Metrics

    Avg Vol (20d)264.7K
    Vol Ratio14.0x(High)
    VWMA (20d)$1.25

    Pivot Points

    R3$1.65
    R2$1.53
    R1$1.44
    Pivot Point$1.32
    S1$1.23
    S2$1.11
    S3$1.02

    Advanced Oscillators

    TSI-10.55
    Ultimate Osc56.0
    KST-9.74

    Financial Data

    QuarterJun 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Cost of Revenue$935$885$1.29K$1.29K$1.86K$1.27KN/A$3.37K$1.69K$2.08KN/AN/A
    Gross Profit-$935-$885-$1.29K-$1.29K-$1.86K-$1.27K-$561-$3.37K-$1.69K-$2.08KN/AN/A
    Operating Expenses$6.41M$2.79M$4.18M$4.18MN/A$3.01M$1.11K$3.64K$1.82K$8.71MN/AN/A
    R&D$1.85M$44.05K$38.37K$38.37K$0$2.22M$1.11K$3.64K$1.82K$4.60M$0$0
    SG&A$0$0$0$0$0$0$0$0$0$0$0$9.25K
    Operating Income-$6.41M-$2.79M-$4.18M-$4.18M$1.67K-$3.01M-$1.67K-$7.01K-$3.51K-$8.71MN/AN/A
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$357.54K$84.58K$119.79K$125.26K$0$758.38K$379$1.05K$527$27.15KN/A$622
    Income Before Tax-$6.35M-$2.59M-$3.87M-$3.87M$2.05K-$4.10M-$2.05K-$8.06K-$4.03K-$8.73M$0$0
    Income Tax Expense$7.93K$52-$1.85M-$1.85M$708-$1.42M-$708$0$0$82.83K$0$0
    Net Income-$6.36M-$2.59M-$2.03M-$2.03M-$1.01K-$2.68M-$1.34KN/A-$4.00K-$8.82MN/AN/A
    EBITDA-$6.41M-$2.79M-$3.75M-$3.75M-$1.88K-$2.67M-$1.67K-$5.22K-$3.51K-$8.71MN/AN/A
    EBIT-$6.41M-$2.79M-$3.75M-$3.75MN/A-$2.68MN/A-$7.01KN/A-$8.71MN/AN/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OKYO

    News

    OKYO Valuation

    P/FCF
    -4.8x
    P/B
    3.6x
    All OKYO metrics

    OKYO Profitability: Margins, ROIC and FCF

    OKYO Pharma (OKYO) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -263.8%
    FCF yield
    -20.7%

    OKYO Pharma Competitors

    The companies most similar to OKYO Pharma (OKYO) include OUTLOOK THERAPEUTICS INC, Coya Therapeutics, Inc. Common Stock and Oncolytics Biotech.

    Sector: Healthcare

    OKYO Analyst Ratings

    OKYO Pharma (OKYO) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0

    OKYO Bull Case vs Bear Case

    Bear case

    • OKYO beat EPS estimates in 16.7% of its last 6 reported quarters.

    OKYO Earnings: Beat Rate and Next Report

    Beat rate
    1 of 6 quarters (16.7%)
    Average surprise
    -36.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    -$0.04
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Updated Jul 25, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About OKYO

    Does OKYO pay dividends?

    OKYO Pharma Limited (OKYO) does not currently pay a regular dividend.

    What is OKYO's market cap?

    OKYO Pharma Limited (OKYO) has a market capitalization of $70.85M with a current stock price of $1.18.

    How do analysts rate OKYO stock?

    3 analysts cover OKYO Pharma Limited (OKYO): 1 rate it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, a consensus of Buy.

    OKYO pages: Overview

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.